NY A00895 | 2023-2024 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 20-0)
Status: Introduced on January 11 2023 - 25% progression
Action: 2024-01-03 - referred to consumer affairs and protection
Pending: Assembly Consumer Affairs and Protection Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 11 2023 - 25% progression
Action: 2024-01-03 - referred to consumer affairs and protection
Pending: Assembly Consumer Affairs and Protection Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
Title
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2024-01-03 | Assembly | referred to consumer affairs and protection |
2023-01-11 | Assembly | referred to consumer affairs and protection |
Same As/Similar To
S03518 (Same As) 2024-01-30 - referred to consumer affairs and protection